Evidence map›Paper›PMID 34088635›Full record

ReviewDiagnostic and interventional imaging2021

Imaging of COVID-19: An update of current evidences.

Shingo Kato, Yoshinobu Ishiwata, Ryo Aoki, Tae Iwasawa, Eri Hagiwara, Takashi Ogura, Daisuke Utsunomiya

Open access · greenAbstract readReview
In one paragraph

Review in Diagnostic and interventional imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. COVID-19 Coagulopathy.Life (Basel, Switzerland) · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Radiology, COVID-19, and the next pandemic.Diagnostic and interventional imaging · 2021
    Article
  13. COVID-19 after 18 months: Where do we stand?Diagnostic and interventional imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shingo KatoDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 236-0004 Yokohama, Kanagawa, Japan. Electronic address: sk513@yokohama-cu.ac.jp.
Yoshinobu IshiwataDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 236-0004 Yokohama, Kanagawa, Japan.
Ryo AokiDepartment of Diagnostic Radiology, Yokohama City University Medical Center, 232-0024 Yokohama, Kanagawa, Japan.
Tae IwasawaDepartment of Diagnostic Radiology, Kanagawa Cardiovascular and Respiratory Center, 236-0051 Yokohama, Kanagawa, Japan.
Eri HagiwaraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 236-0051 Yokohama, Kanagawa, Japan.
Takashi OguraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 236-0051 Yokohama, Kanagawa, Japan.
Daisuke UtsunomiyaDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 236-0004 Yokohama, Kanagawa, Japan.
Kanagawa Cardiovascular and Respiratory Center · JPYokohama City University · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported as a global emergency. As respiratory dysfunction is a major clinical presentation of COVID-19, chest computed tomography (CT) plays a central role in the diagnosis and management of patients with COVID-19. Recent advances in imaging approaches using artificial intelligence have been essential as a quantification and diagnostic tool to differentiate COVID-19 from other respiratory infectious diseases. Furthermore, cardiovascular involvement in patients with COVID-19 is not negligible and may result in rapid worsening of the disease and sudden death. Cardiac magnetic resonance imaging can accurately depict myocardial involvement in SARS-CoV-2 infection. This review summarizes the role of the radiology department in the management and the diagnosis of COVID-19, with a special emphasis on ultra-high-resolution CT findings, cardiovascular complications and the potential of artificial intelligence.

Indexed as

COVID-19Heart DiseasesArtificial IntelligenceHumansTomography, X-Ray ComputedArtificial intelligenceCardiac magnetic resonanceComputed tomographyCOVID-19Pulmonary embolism

Identifiers

PMID34088635
PMCPMC8148573
OpenAlexW3165043677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.